Skip to main content
. 2019 Apr 17;11:86. doi: 10.3389/fnagi.2019.00086

Figure 4.

Figure 4

Subgroup analysis of the MMSE score after treatment (2.4.1) HBOT+CT+ oxiracetam vs. CT+ oxiracetam, (2.4.2) HBOT+CT+ butylphthalide vs. CT + butylphthalide, and (2.4.3) HBOT+CT+ donepezil vs. CT+ donepezil, (2.4.4) HBOT+CT+ nicergoline vs. CT+ nicergoline, (2.4.5) HBOT+CT vs. CT.